Concepedia
Statistics
Publications
15
Citations
822
H-Index
14
Active since
2007
Affiliations
Kyoto University Hospital(Current)
Kyoto Prefectural University of Medicine
Kyoto University
Saga University
Kyoto University of Education
Ruriko Tanaka is an author at Kyoto University Hospital specializing in medicine, oncology, and pharmacology.
Publications per year
2007–2017
Gilteritinib, a FLT3/AXL inhibitor, shows antileukemic activity in mouse models of FLT3 mutated acute myeloid leukemia
Masamichi Mori, Naoki Kaneko, Yoko Ueno et al. · Investigational New Drugs · 2017 · 254 citations · Full text
Medicine, Oncology, Pharmacology +16
ABT‐737 is a useful component of combinatory chemotherapies for chronic myeloid leukaemias with diverse drug‐resistance mechanisms
Junya Kuroda, Shinya Kimura, Michael Andreeff et al. · British Journal of Haematology · 2007 · 84 citations
Medicine, Oncology, Pharmacology +17
Activity of the multitargeted kinase inhibitor, AT9283, in imatinib-resistant BCR-ABL–positive leukemic cells
Ruriko Tanaka, Matthew Squires, Shinya Kimura et al. · Blood · 2010 · 71 citations · Full text
Medicine, Oncology, Pharmacology +6
β-Catenin Small Interfering RNA Successfully Suppressed Progression of Multiple Myeloma in a Mouse Model
Eishi Ashihara, Eri Kawata, Yoko Nakagawa et al. · Clinical Cancer Research · 2009 · 65 citations
Life Sciences, Molecular Biology, Oncology +14
Administration of PLK-1 small interfering RNA with atelocollagen prevents the growth of liver metastases of lung cancer
Eri Kawata, Eishi Ashihara, Shinya Kimura et al. · Molecular Cancer Therapeutics · 2008 · 58 citations
Pharmacy, Oncology, Pharmacology +17
1–5 of 15